Rfp Financial Group LLC Bristol Myers Squibb CO Transaction History

Rfp Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $11,914 - $15,685	296 Added 28.99%	1,317 $54,000
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $46,876 - $53,148	-977 Reduced 48.9%	1,021 $55,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $38,207 - $42,721	-660 Reduced 24.83%	1,998 $115,000
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $136,976 - $152,091	2,150 Added 423.23%	2,658 $169,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $141,276 - $160,239	-2,150 Reduced 80.89%	508 $35.2 Million
Q4 2022 Jan 24, 2023	BUY	$68.48 - $81.09 $182,019 - $215,537	2,658 New	2,658 $191 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.